retatrutide triple agonist glp-1 gip glucagon phase 2 obesity receptor Agonism Based Therapies for Retatrutide (LY-3437943) Market Analysis, 2033:
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





























:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)